A scrappy upstart in the pain pill business takes on mighty Purdue Pharma
(By Rebecca Robbins for STAT) CANTON, Mass. — Collegium Pharmaceutical, the scrappy upstart taking on the mighty opioid maker Purdue
Read More(By Rebecca Robbins for STAT) CANTON, Mass. — Collegium Pharmaceutical, the scrappy upstart taking on the mighty opioid maker Purdue
Read More(By Julie Spitzer for Becker’s Hospital Review) Investments in medical and health research and development grew 20.6 percent between 2013
Read More(By Alison Kodjak for NPR) At MedStar Washington Hospital Center, doctors and nurses are moving as many patients as they
Read More(By Jocelyn Wiener for Kaiser Health News) Rachael Norman needed to submit a pile of out-of-network medical bills to her
Read More(By Jessica Kim Cohen for Becker’s Hospital Review) The majority of patients — 75 percent — cited information on whether
Read More(By Joe Palca for NPR) Let’s say you’re a scientist, and you’ve invented what you think is a useful treatment
Read More(By Chad Terhune for California Healthline produced by Kaiser Health News) Seeking to prevent superbug outbreaks, federal health officials said
Read More(By Adam Feuerstein for STAT) The age of RNA interference drugs has arrived. Alnylam Pharmaceuticals announced positive results Wednesday from
Read More(By Rob Stein for NPR) For the first time, scientists have edited the DNA in human embryos to make a
Read MoreIn a survey by HealthMine of 500 Medicare health consumers, found that 57 percent of members aged 65 plus said
Read More